The company seems to be emphasizing RSV which suggests a 235 partnership is not imminent. This variant has potential to be bad and a bad Covid season could change that, but as I have said before my guess is that data from PFE and Shionogi are gating factors at this point.
News 
Market Data 
Discover 
AI
